13F-HR filed by Cutter Capital Management, LP
Cutter Capital Management, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 27 holding rows worth $331,287,284.
- Accession
- 0001214659-24-014671
- Filer
- CIK 1983313
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 27 entries on the cover page, a total value of $331,287,284 stated on the cover page (in dollars after the unit check, H1), rows summing to $331,287,284 with VALUE read as dollars as filed, 13F file number 028-23904. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 273,533 | $22,519,972 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 175,600 | $21,739,280 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 292,959 | $20,099,917 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 64,201 | $20,059,602 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 692,300 | $18,255,951 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 76,726 | $17,786,621 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 960,400 | $17,460,072 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 227,637 | $15,251,679 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 343,130 | $15,197,228 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 365,000 | $15,001,500 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 911,900 | $14,818,375 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 89,379 | $14,121,882 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 236,900 | $12,835,242 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,975,298 | $12,207,342 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 201,497 | $10,882,853 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 187,000 | $10,320,530 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 733,001 | $10,305,994 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 295,771 | $8,923,411 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 400,000 | $8,480,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 230,000 | $8,321,400 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 311,700 | $7,895,361 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 160,166 | $7,633,512 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 222,985 | $5,211,159 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 185,200 | $5,181,896 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 465,300 | $5,048,505 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 20,000 | $3,160,000 | dollars as filed | call |
| PERRIGO CO PLC SHS | G97822103 | Stock | 100,000 | $2,568,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-24-014671 | this filing | 2024-08-14 | acceptance time not in the bulk data set |